Continuous Control of Tracheal Cuff Pressure and Microaspiration in Critically Ill Patients
- Conditions
- Critically Ill
- Interventions
- Device: Continuous control of cuff pressureDevice: Manual control of cuff pressure
- Registration Number
- NCT01082666
- Lead Sponsor
- University Hospital, Lille
- Brief Summary
We hypothesized that continuous control of tracheal cuff pressure would reduce microaspiration of gastric content as determined by pepsin level in tracheal aspirate.
- Detailed Description
Randomized controlled open label study, performed in a 10-bed ICU. All patients intubated with a PVC-cuffed tracheal tube and receiving enteral nutrition who require at least 48 h of mechanical ventilation are eligible. Patients receive continuous control of cuff pressure using a pneumatic device (intervention group) or manual control using a manometer (control group). Target cuff pressure is 25 cmH2O.
In all patients, pepsin is measured in tracheal aspirate during a 48-h period after inclusion, as proxy for gastric content aspiration. In addition tracheobronchial colonization and ventilator associated pneumonia rates will be compared between the two groups.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 122
- age > or = 18 years
- tracheal intubation using a polyvinylchloride tube
- predictible duration of mechanical ventilation > 48 h
- enteral nutrition
- refuse to participate to the study
- no informed consent
- contra-indication for semirecumbment position
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Continuous control Continuous control of cuff pressure Continuous control of cuff pressure using a pneumatic device Manual control Manual control of cuff pressure Manual control of cuff pressure is a routine practice in ICU patients
- Primary Outcome Measures
Name Time Method Pepsin level in tracheal aspirate 48 h after randomization
- Secondary Outcome Measures
Name Time Method Ventilator-associated pneumonia, tracheobronchial colonization, tracheal ischemic lesions day 28 after randomization
Trial Locations
- Locations (1)
ICU, Calmette Hospital, University Hospital of Lille
🇫🇷Lille, Nord, France